0
0

Cart (0)

Home > Categories > Apixaban

Apixaban

Sort by
Wishlist

N-Formyl-1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopipe...

  • CAT NUMBER DCTI-C-2301
  • CAS NUMBER 1351611-14-7
  • MOLECULAR FORMULA C26H25N5O5
  • MOLECULAR WEIGHT 487.52
Wishlist
LOAD MORE
You're viewed all 19 products
References
FAQ's

References

  1. Pinto, Donald; Quan, Mimi; Orwat, Michael; Li, Yun-Long; Han, Wei; Qiao, Jennifer; Lam, Patrick; Koch, Stephanie, Lactam-Containing Compounds And Derivatives Thereof As Factor Xa Inhibitors, Bristol-Myers Squibb Company, United States, EP1427415B1, August 12, 2009
  2. Delavenne, Xavier; Mismetti, Patrick; Basset, Thierry, Rapid determination of apixaban concentration in human plasma by liquid chromatography/tandem mass spectrometry: Application to pharmacokinetic study, Journal of Pharmaceutical and Biomedical Analysis, Volume: 78-79, Pages: 150-153, 2013

Frequently Asked Questions

Impurity profiling is a critical step in Apixaban manufacturing as it helps identify, characterize, and quantify impurities present in the drug substance. It helps to optimize the manufacturing process and ensure the drug’s quality, safety, and efficacy.

Common impurities found in Apixaban include degradation products and residual solvents and may result from the manufacturing process, such as unreacted starting materials, reagents, or by-products.

Apixaban impurities are removed through purification steps such as recrystallization, distillation, or chromatography.

Apixaban impurities are stored at a controlled room temperature between 2-8 °C or as indicated on the Certificate of Analysis (CoA).

Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.

Back to Top
Product has been added to your cart
jQuery(window).on('load', function() { $('input[name="productname"]').val($('.product_title').html()); });